SE510812C2 - (-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1- yl)fenoxi)smörsyra som cellulär adhesionsinhibitor - Google Patents
(-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1- yl)fenoxi)smörsyra som cellulär adhesionsinhibitorInfo
- Publication number
- SE510812C2 SE510812C2 SE9700203A SE9700203A SE510812C2 SE 510812 C2 SE510812 C2 SE 510812C2 SE 9700203 A SE9700203 A SE 9700203A SE 9700203 A SE9700203 A SE 9700203A SE 510812 C2 SE510812 C2 SE 510812C2
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutically acceptable
- optically active
- active compound
- ester
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/457,538 US5652242A (en) | 1993-03-29 | 1995-06-01 | Heterocyclic derivatives |
GBGB9518188.9A GB9518188D0 (en) | 1995-09-07 | 1995-09-07 | Optically active derivative |
PCT/GB1996/001260 WO1996038416A1 (en) | 1995-06-01 | 1996-05-28 | (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor |
Publications (3)
Publication Number | Publication Date |
---|---|
SE9700203D0 SE9700203D0 (sv) | 1997-01-24 |
SE9700203L SE9700203L (sv) | 1997-01-24 |
SE510812C2 true SE510812C2 (sv) | 1999-06-28 |
Family
ID=26307696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9700203A SE510812C2 (sv) | 1995-06-01 | 1997-01-24 | (-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1- yl)fenoxi)smörsyra som cellulär adhesionsinhibitor |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0796247A1 (xx) |
JP (1) | JP2885941B2 (xx) |
KR (1) | KR100245957B1 (xx) |
AT (1) | AT406675B (xx) |
AU (1) | AU710105B2 (xx) |
BE (1) | BE1009520A5 (xx) |
BR (1) | BR9606409A (xx) |
CA (1) | CA2194397A1 (xx) |
CH (1) | CH691808A5 (xx) |
CZ (1) | CZ26997A3 (xx) |
DE (1) | DE19680509T1 (xx) |
DK (1) | DK10697A (xx) |
ES (1) | ES2137886B1 (xx) |
FI (1) | FI970393A (xx) |
GB (1) | GB2304340B (xx) |
GR (1) | GR1002702B (xx) |
HU (1) | HUP9700274A3 (xx) |
IE (1) | IE960405A1 (xx) |
IL (1) | IL118477A0 (xx) |
IT (1) | IT1290839B1 (xx) |
LU (1) | LU90008B1 (xx) |
MC (1) | MC2418A1 (xx) |
MX (1) | MX9700379A (xx) |
NL (1) | NL1003243C2 (xx) |
NO (1) | NO307460B1 (xx) |
NZ (1) | NZ308597A (xx) |
PL (1) | PL318440A1 (xx) |
SE (1) | SE510812C2 (xx) |
SK (1) | SK13097A3 (xx) |
TR (1) | TR199700020T1 (xx) |
WO (1) | WO1996038416A1 (xx) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0100158A3 (en) * | 1982-07-28 | 1985-03-27 | The Upjohn Company | (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters |
GB8609630D0 (en) * | 1986-04-19 | 1986-05-21 | Pfizer Ltd | Anti-arrhythmia agents |
SK120895A3 (en) * | 1993-03-29 | 1996-06-05 | Zeneca Ltd | Pyridine derivatives, process for preparing the same and intermediate products in this process and pharmaceutical compositions containing them |
NZ262942A (en) * | 1993-03-29 | 1997-07-27 | Zeneca Ltd | Pyridyl substituted piperazine and various other derivatives of azaheteroaryl substituted piperazines; pharmaceutical compositions |
-
1996
- 1996-05-28 GR GR960100176A patent/GR1002702B/el not_active IP Right Cessation
- 1996-05-28 EP EP96919906A patent/EP0796247A1/en not_active Withdrawn
- 1996-05-28 HU HU9700274A patent/HUP9700274A3/hu unknown
- 1996-05-28 BR BR9606409A patent/BR9606409A/pt not_active Application Discontinuation
- 1996-05-28 MX MX9700379A patent/MX9700379A/es unknown
- 1996-05-28 WO PCT/GB1996/001260 patent/WO1996038416A1/en not_active IP Right Cessation
- 1996-05-28 NZ NZ308597A patent/NZ308597A/en unknown
- 1996-05-28 CH CH00224/97A patent/CH691808A5/de not_active IP Right Cessation
- 1996-05-28 DE DE19680509T patent/DE19680509T1/de not_active Withdrawn
- 1996-05-28 ES ES009750006A patent/ES2137886B1/es not_active Expired - Fee Related
- 1996-05-28 PL PL96318440A patent/PL318440A1/xx unknown
- 1996-05-28 GB GB9627127A patent/GB2304340B/en not_active Expired - Fee Related
- 1996-05-28 CZ CZ97269A patent/CZ26997A3/cs unknown
- 1996-05-28 JP JP8536281A patent/JP2885941B2/ja not_active Expired - Fee Related
- 1996-05-28 TR TR97/00020T patent/TR199700020T1/xx unknown
- 1996-05-28 AU AU58272/96A patent/AU710105B2/en not_active Ceased
- 1996-05-28 KR KR1019970700532A patent/KR100245957B1/ko not_active IP Right Cessation
- 1996-05-28 AT AT0900596A patent/AT406675B/de active
- 1996-05-28 SK SK130-97A patent/SK13097A3/sk unknown
- 1996-05-28 CA CA002194397A patent/CA2194397A1/en not_active Abandoned
- 1996-05-29 MC MC2347A patent/MC2418A1/xx unknown
- 1996-05-30 IL IL11847796A patent/IL118477A0/xx unknown
- 1996-05-31 NL NL1003243A patent/NL1003243C2/xx not_active IP Right Cessation
- 1996-05-31 IT IT96MI001113A patent/IT1290839B1/it active IP Right Grant
- 1996-05-31 IE IE960405A patent/IE960405A1/en not_active IP Right Cessation
- 1996-05-31 BE BE9600491A patent/BE1009520A5/fr not_active IP Right Cessation
-
1997
- 1997-01-22 LU LU90008A patent/LU90008B1/fr active
- 1997-01-24 SE SE9700203A patent/SE510812C2/sv not_active IP Right Cessation
- 1997-01-30 DK DK010697A patent/DK10697A/da not_active Application Discontinuation
- 1997-01-30 FI FI970393A patent/FI970393A/fi unknown
- 1997-01-31 NO NO970437A patent/NO307460B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110831945B (zh) | 用于治疗疼痛的11,13-修饰的石房蛤毒素类化合物 | |
JP2020528918A (ja) | アンドロゲン受容体の標的化分解のための化合物および方法 | |
MX2015002695A (es) | Derivados biciclicos fusionados de sulfamoilo y su uso como medicamentos para el tratamiento de la hepatitis b. | |
EP3398598B1 (en) | Sulfonamide derivative and preparation method and use thereof | |
CN108026073B (zh) | 作为毒蕈碱性m1受体正向别构调节剂的氟吲哚衍生物 | |
EP1641787B1 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
CN112118891B (zh) | 作为流感病毒复制抑制剂的稠和多环吡啶酮化合物 | |
CZ288895A3 (en) | Oxazolidinone derivative, process of its preparation and pharmaceutical composition containing thereof | |
FR2758329A1 (fr) | Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique | |
US20120122920A1 (en) | Libraries of n-substituted-n-phenylethylsulfonamides for drug discovery | |
SE510812C2 (sv) | (-)-(3R)-3-metyl-4-(4-(4-(4-pyridyl)piperazin-1- yl)fenoxi)smörsyra som cellulär adhesionsinhibitor | |
WO1996020179A1 (en) | Piperazine-2,5-dione derivatives as modulators of multi-drug resistance | |
CZ288764B6 (cs) | Fenylamidinové deriváty, způsob jejich výroby a farmaceutický prostředek s jejich obsahem | |
US5675011A (en) | Process for producing pyrrolidine derivative and salt thereof | |
JP2003520791A (ja) | 置換フェニルアミジン、これらの化合物を含む医薬組成物及びこれらの調製方法 | |
SK283634B6 (sk) | Butadiénový, aminobutadiénový a pyrolidínový derivát a spôsoby ich prípravy | |
KR100551944B1 (ko) | 신규에폭시숙신아미드유도체또는그의염 | |
FR2734818A1 (fr) | Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazine-1-yl- phenoxy}-butyrique, procede pour sa preparation et composition pharmaceutique le contenant | |
TW200403063A (en) | Novel compounds | |
JPH02311479A (ja) | キノリン誘導体 | |
MXPA06004271A (en) | Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |